TY - JOUR
T1 - DNA cytometry testing for cervical cancer screening
T2 - Approaches and reporting standards for new technologies
AU - Colditz, Graham A.
AU - Crowley, John
N1 - Copyright:
Copyright 2012 Elsevier B.V., All rights reserved.
PY - 2011/11/15
Y1 - 2011/11/15
N2 - Evaluation of new technologies requires rigorous methods to provide unbiased estimates of the performance and so inform future clinical practice. We review evidence on DNA cytometry reported earlier in this journal and point to the standards for reporting of diagnostic accuracy as a metric against which this article can be evaluated. The cross-sectional nature of the data and incomplete reporting limit the clinical utility of the study. With application of improved reporting standards for diagnostic tests and improved design and evaluation of new technologies for screening, we may better inform practices to improve clinical outcomes and population health.
AB - Evaluation of new technologies requires rigorous methods to provide unbiased estimates of the performance and so inform future clinical practice. We review evidence on DNA cytometry reported earlier in this journal and point to the standards for reporting of diagnostic accuracy as a metric against which this article can be evaluated. The cross-sectional nature of the data and incomplete reporting limit the clinical utility of the study. With application of improved reporting standards for diagnostic tests and improved design and evaluation of new technologies for screening, we may better inform practices to improve clinical outcomes and population health.
UR - http://www.scopus.com/inward/record.url?scp=81255150604&partnerID=8YFLogxK
U2 - 10.1158/1078-0432.CCR-11-1862
DO - 10.1158/1078-0432.CCR-11-1862
M3 - Short survey
C2 - 21940755
AN - SCOPUS:81255150604
VL - 17
SP - 6971
EP - 6972
JO - Clinical Cancer Research
JF - Clinical Cancer Research
SN - 1078-0432
IS - 22
ER -